Brokerages Set Celsius Holdings, Inc. (NASDAQ:CELH) Target Price at $54.40

Shares of Celsius Holdings, Inc. (NASDAQ:CELH) have been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have assigned a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $54.40.

Several research analysts have recently issued reports on CELH shares. Jefferies Financial Group decreased their price target on Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. LADENBURG THALM/SH SH decreased their price target on Celsius from $72.00 to $68.00 and set a “neutral” rating for the company in a research note on Monday, October 21st. Stifel Nicolaus decreased their price target on Celsius from $51.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, November 7th. Truist Financial raised their target price on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research note on Wednesday, October 16th. Finally, Roth Mkm decreased their target price on Celsius from $43.00 to $40.00 and set a “buy” rating for the company in a research note on Thursday, November 7th.

Insider Activity at Celsius

In related news, CEO John Fieldly sold 74,847 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total value of $2,454,981.60. Following the completion of the sale, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at approximately $59,449,672. This represents a 3.97 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Celsius

Several hedge funds have recently bought and sold shares of CELH. S.A. Mason LLC purchased a new stake in Celsius in the 2nd quarter worth about $30,000. EverSource Wealth Advisors LLC lifted its stake in Celsius by 3,116.7% in the 1st quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after acquiring an additional 374 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Celsius in the 3rd quarter worth about $34,000. Signaturefd LLC lifted its stake in Celsius by 48.3% in the 3rd quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after acquiring an additional 378 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. raised its stake in shares of Celsius by 353.1% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock worth $37,000 after purchasing an additional 505 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Celsius Stock Performance

NASDAQ:CELH opened at $28.64 on Friday. Celsius has a 1 year low of $25.23 and a 1 year high of $99.62. The stock has a market cap of $6.73 billion, a price-to-earnings ratio of 39.78, a PEG ratio of 3.27 and a beta of 1.86. The business has a fifty day moving average of $30.26 and a 200-day moving average of $45.07.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.